A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE3

Conditions

Dystrophic Epidermolysis Bullosa · DEB - Dystrophic Epidermolysis Bullosa · Recessive Dystrophic Epidermolysis Bullosa · Dominant Dystrophic Epidermolysis Bullosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mission Dermatology Center, Rancho Santa Margarita, California, United States
Contact: Study coordinator (Shireen Guide, MD) · admin@missiondermatology.com · 949-858-3376
Study coordinator · sguide@gmail.com
Skin Research Institute, Coral Gables, Florida, United States
Contact: Study coordinator (Alex Cazzaniga) · info@srinsitute.org · 305-444-5770
UMass Memorial Medical Center, Worcester, Massachusetts, United States
Contact: Study coordinator (Priscilla Romano, MD) · priscilla.romano@umassmed.edu · 508-856-1706
Contact: Study coordinator (Isaac (Li-Chi) Chen, MD) · lichi.chen6@umassmed.edu · 774-455-4758
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Bret Augsburger, CCRP) · Bret.Augsburger@cchmc.org · 513-636-2009
Texas Dermatology and Laser Specialists, San Antonio, Texas, United States
Contact: Study coordinator (Jennifer Patterson) · jpatterson@texasdls.com · 210-852-2779

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Epidermolysis Bullosa (EB) · Dystrophic Epidermolysis Bullosa · Junctional Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE2

Paris, France · Athens, Greece

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Epidermolysis Bullosa · Junctional Epidermolysis Bullosa · Epidermolysis Bullosa, Dystrophic

Abroad (travel likely)RecruitingPHASE3

Fukuoka, Japan · Fukuoka, Japan

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Epidermolysis Bullosa · Epidermolysis Bullosa Acquisita · Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Redwood City, United States

Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa · Wound Heal

Abroad (travel likely)RecruitingPHASE1, PHASE2

Isfahan, Iran